Award Abstract # 1750542
CAREER: Mechanistic Investigations to Enable Rationally Designed Biomanufacturing of Mesenchymal Stem Cell Exosomes

NSF Org: CBET
Division of Chemical, Bioengineering, Environmental, and Transport Systems
Recipient: UNIVERSITY OF MARYLAND, COLLEGE PARK
Initial Amendment Date: March 12, 2018
Latest Amendment Date: May 29, 2020
Award Number: 1750542
Award Instrument: Continuing Grant
Program Manager: Steven Peretti
speretti@nsf.gov
 (703)292-4201
CBET
 Division of Chemical, Bioengineering, Environmental, and Transport Systems
ENG
 Directorate for Engineering
Start Date: March 15, 2018
End Date: February 28, 2023 (Estimated)
Total Intended Award Amount: $521,587.00
Total Awarded Amount to Date: $607,061.00
Funds Obligated to Date: FY 2018 = $409,016.00
FY 2019 = $112,571.00

FY 2020 = $85,474.00
History of Investigator:
  • Steven Jay (Principal Investigator)
    smjay@umd.edu
Recipient Sponsored Research Office: University of Maryland, College Park
3112 LEE BUILDING
COLLEGE PARK
MD  US  20742-5100
(301)405-6269
Sponsor Congressional District: 04
Primary Place of Performance: University of Maryland College Park
3112 Lee Bldg 7809 Regents Drive
College Park
MD  US  20742-5141
Primary Place of Performance
Congressional District:
04
Unique Entity Identifier (UEI): NPU8ULVAAS23
Parent UEI: NPU8ULVAAS23
NSF Program(s): Cellular & Biochem Engineering
Primary Program Source: 01001819DB NSF RESEARCH & RELATED ACTIVIT
01001920DB NSF RESEARCH & RELATED ACTIVIT

01002021DB NSF RESEARCH & RELATED ACTIVIT
Program Reference Code(s): 1757, 1045, 7619
Program Element Code(s): 149100
Award Agency Code: 4900
Fund Agency Code: 4900
Assistance Listing Number(s): 47.041

ABSTRACT

Therapies that use a patient's own cells show great promise in the treatment of a variety of diseases, including cancer. Manufacturing therapeutic cells reliably is a major challenge. This project will define design and control parameters to make this possible. The initial focus is on producing a cell-based therapy for wound healing. If successful, the technology that is developed could lead to breakthroughs in treatments for other life-threatening diseases. An education plan will promote opportunities and training at the high school through post-graduate levels. A progressive program at the high school level that impacts hundreds of students per year will increase exposure to research opportunities and promote retention in STEM career paths. Community outreach programs will also be supported, and research findings will be integrated to enhance these programs.

Establishing new criteria for rational design of biomanufacturing approaches for therapeutic mesenchymal stem/stromal cell (MSC) exosomes is the focus of this project. Exosomes have therapeutic bioactivity, including vascularization. Many of the therapeutic effects associated with cell-based therapies are now being ascribed to protein, nucleic acid, and/or lipid transfer from exosomes and other extracellular vesicles secreted by implanted cells. The general hypothesis is that MSC exosome production and therapeutic bioactivity are defined by the cell culture microenvironment and the status of producer MSCs. The research objectives are to: 1) investigate the mechanism of vascularization bioactivity; 2) investigate the mechanism of cell density effects on production; and 3) develop quantitative predictive criteria to enable quality control of exosome production. If successful, this technology will impact patients by enabling new therapeutic options for wound repair, and ischemic and other diseases.

This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

PUBLICATIONS PRODUCED AS A RESULT OF THIS RESEARCH

Note:  When clicking on a Digital Object Identifier (DOI) number, you will be taken to an external site maintained by the publisher. Some full text articles may not yet be available without a charge during the embargo (administrative interval).

Some links on this page may take you to non-federal websites. Their policies may differ from this site.

(Showing: 1 - 10 of 12)
Born, Louis J. and Chang, KaiHua and Shoureshi, Pouria and Lay, Frank and Bengali, Sameer and Hsu, Angela Ting Wei and Abadchi, Sanaz Nourmohammadi and Harmon, John W. and Jay, Steven M. "HOTAIRLoaded Mesenchymal Stem/Stromal Cell Extracellular Vesicles Enhance Angiogenesis and Wound Healing" Advanced Healthcare Materials , v.11 , 2021 https://doi.org/10.1002/adhm.202002070 Citation Details
Born, Louis J. and Harmon, John W. and Jay, Steven M. "Therapeutic potential of extracellular vesicleassociated long noncoding RNA" Bioengineering & Translational Medicine , v.5 , 2020 https://doi.org/10.1002/btm2.10172 Citation Details
Born, Louis J. and McLoughlin, Shannon T. and Dutta, Dipankar and Mahadik, Bhushan and Jia, Xiaofeng and Fisher, John P. and Jay, Steven M. "Sustained released of bioactive mesenchymal stromal cellderived extracellular vesicles from 3Dprinted gelatin methacrylate hydrogels" Journal of Biomedical Materials Research Part A , v.110 , 2022 https://doi.org/10.1002/jbm.a.37362 Citation Details
Jeyaram, Anjana and Lamichhane, Tek N. and Wang, Sheng and Zou, Lin and Dahal, Eshan and Kronstadt, Stephanie M. and Levy, Daniel and Parajuli, Babita and Knudsen, Daphne R. and Chao, Wei and Jay, Steven M. "Enhanced Loading of Functional miRNA Cargo via pH Gradient Modification of Extracellular Vesicles" Molecular Therapy , v.28 , 2020 https://doi.org/10.1016/j.ymthe.2019.12.007 Citation Details
Kronstadt, Stephanie M. and Patel, Divya B. and Born, Louis J. and Levy, Daniel and Lerman, Max J. and Mahadik, Bhushan and McLoughlin, Shannon T. and Fasuyi, Arafat and Fowlkes, Lauren and Van Heyningen, Lauren Hoorens and Aranda, Amaya and Abadchi, Sana "Mesenchymal Stem Cell Culture within Perfusion Bioreactors Incorporating 3DPrinted Scaffolds Enables Improved Extracellular Vesicle Yield with Preserved Bioactivity" Advanced Healthcare Materials , v.12 , 2023 https://doi.org/10.1002/adhm.202300584 Citation Details
Levy, Daniel and Jeyaram, Anjana and Born, Louis J. and Chang, Kai-Hua and Abadchi, Sanaz Nourmohammadi and Hsu, Angela Ting and Solomon, Talia and Aranda, Amaya and Stewart, Samantha and He, Xiaoming and Harmon, John W. and Jay, Steven M. "Impact of storage conditions and duration on function of native and cargo-loaded mesenchymal stromal cell extracellular vesicles" Cytotherapy , v.25 , 2023 https://doi.org/10.1016/j.jcyt.2022.11.006 Citation Details
Patel, Divya B. and Luthers, Christopher R. and Lerman, Max J. and Fisher, John P. and Jay, Steven M. "Enhanced extracellular vesicle production and ethanol-mediated vascularization bioactivity via a 3D-printed scaffold-perfusion bioreactor system" Acta Biomaterialia , 2018 10.1016/j.actbio.2018.11.024 Citation Details
Patel, Divya B. and Santoro, Marco and Born, Louis J. and Fisher, John P. and Jay, Steven M. "Towards rationally designed biomanufacturing of therapeutic extracellular vesicles: impact of the bioproduction microenvironment" Biotechnology Advances , v.36 , 2018 10.1016/j.biotechadv.2018.09.001 Citation Details
Piard, Charlotte and Jeyaram, Anjana and Liu, Yi and Caccamese, John and Jay, Steven M. and Chen, Yu and Fisher, John "3D printed HUVECs/MSCs cocultures impact cellular interactions and angiogenesis depending on cell-cell distance" Biomaterials , v.222 , 2019 10.1016/j.biomaterials.2019.119423 Citation Details
Russell, Ashley E. and Sneider, Alexandra and Witwer, Kenneth W. and Bergese, Paolo and Bhattacharyya, Suvendra N. and Cocks, Alexander and Cocucci, Emanuele and Erdbrügger, Uta and Falcon-Perez, Juan M. and Freeman, David W. and Gallagher, Thomas M. and "Biological membranes in EV biogenesis, stability, uptake, and cargo transfer: an ISEV position paper arising from the ISEV membranes and EVs workshop" Journal of Extracellular Vesicles , v.8 , 2019 10.1080/20013078.2019.1684862 Citation Details
Shimada, Briana K. and Yang, Yang and Zhu, Jing and Wang, Sheng and Suen, Andrew and Kronstadt, Stephanie M. and Jeyaram, Anjana and Jay, Steven M. and Zou, Lin and Chao, Wei "Extracellular miR-146a-5p Induces Cardiac Innate Immune Response and Cardiomyocyte Dysfunction" ImmunoHorizons , v.4 , 2020 https://doi.org/10.4049/immunohorizons.2000075 Citation Details
(Showing: 1 - 10 of 12)

PROJECT OUTCOMES REPORT

Disclaimer

This Project Outcomes Report for the General Public is displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed in this Report are those of the PI and do not necessarily reflect the views of the National Science Foundation; NSF has not approved or endorsed its content.

Extracellular vesicles (EVs) are produced by essentially all types of human cells and are part of the communication network that keeps cells in their optimal state and allows them to respond to changes in their environment. As such, they can be harnessed to transfer therapeutic cargo to cells in the case of disease or injury, and thus represent a promising therapeutic technology for development. This project focused on increasing understanding of EV biology and applying what was learned to improving the biomanufacturing of this emerging class of biotechnology. One objective was to better understand the way in which EVs from mesenchymal stem cells (MSCs) are able to promote certain biological outcomes, such as the growth of new blood vessels. Our work revealed that a specific type of RNA, call long non-coding RNA (lncRNA), plays an important role in this process. We identified particular lncRNAs of interest for therapeutic delivery and demonstrated that EVs loaded with these lncRNAs could indeed improve therapeutic outcomes, specifically in a wound healing model. Another objective was to understand how the condition of cells when they produce EVs affects the EVs themselves. We found that cells respond profoundly to the mechanical stimuli they experience with respect to the amount and activity of the EVs they produce. This knowledge can be used to design devices and systems for future scalable biomanufacturing of therapeutic EVs. A final research objective was to improve quality control of EV production. We made important strides in identifying conditions for production, separation, and storage of EVs that should help normalize EV preparations towards generating a more reproducible and reliable product.

 

This project also contributed to broader impacts beyond research. A partnership was established with Eleanor Roosevelt High School in Greenbelt, MD allowing students to get hands-on experience in bioengineering research as well as an introduction to college-level engineering facilities and operations. This was accomplished via internships as well as a “BIOE Crash Course” program that brought dozens of students to the University of Maryland campus for hands-on activities. There was also strong integration with community research, education, and diversity programs throughout the project, as students associated with the Women in Engineering program as well as the Louis Stokes Alliance for Minority Participation were able to work on the project and learn more about EVs and biomanufacturing. Finally, training and educational advances were made, as numerous students from the high school, undergraduate, and graduate levels participated in research and received teaching on EVs and biomanufacturing, which was new and additive to their normal curriculum. Overall, the research and educational goals of this project were achieved, with the outcome of moving the field of EV biomanufacturing closer to a clinical reality that could eventually benefit millions of patients and provide biotechnology job opportunities for many in the community.

 


Last Modified: 06/23/2023
Modified by: Steven M Jay

Please report errors in award information by writing to: awardsearch@nsf.gov.

Print this page

Back to Top of page